The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
Open accessAbstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) is a highly pathogenic emergent virus which replicates in cells that can express ABH histo-blood group antigens. The heavily glycosylated SARS-CoV spike (S) protein binds to angiotensin-converting enzyme 2 which serves as a cellular receptor. Epidemiological analysis of a hospital outbreak in Hong Kong revealed that blood group O was associated with a low risk of infection. In this study, we used a cellular model of adhesion to investigate whether natural antibodies of the ABO system could block the S protein and angiotensin-converting enzyme 2 interaction. To this aim, a C-terminally EGFP-tagged S protein was expressed in chinese hamster ovary cells cotransfected with an alpha1,2-fucosyltransferase and an A-transferase in order to coexpress the S glycoprotein ectodomain and the A antigen at the cell surface. We observed that the S protein/angiotensin-converting enzyme 2-dependent adhesion of these cells to an angiotensin-converting enzyme 2 expressing cell line was specifically inhibited by either a monoclonal or human natural anti-A antibodies, indicating that these antibodies may block the interaction between the virus and its receptor, thereby providing protection. In order to more fully appreciate the potential effect of the ABO polymorphism on the epidemiology of SARS, we built a mathematical model of the virus transmission dynamics that takes into account the protective effect of ABO natural antibodies. The model indicated that the ABO polymorphism could contribute to substantially reduce the virus transmission, affecting both the number of infected individuals and the kinetics of the epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Singh, R. P., Kurz, J., & Boiteau, G. (1996) · Journal of Virological Methods · doi:10.1016/0166-0934(96)02096-4 · Cited by 2,552
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China
The Chinese SARS Molecular Epidemiology Consortium (2004) · Science · doi:10.1126/science.1092002 · Cited by 775
Wong, S. K., Li, W., Moore, M. J., Choe, H., & Farzan, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300520200 · Cited by 694
Pathology and Pathogenesis of Severe Acute Respiratory Syndrome
Gu, J., & Korteweg, C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061088 · Cited by 592
Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic
Anderson, R. M., Fraser, C., Ghani, A. C., Donnelly, C. A., Riley, S., Ferguson, N. M., Leung, G. M., Lam, T. H., & Hedley, A. J. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2004.1490 · Cited by 509 · cited 1×
“Since the epidemiology of SARS has been well documented (Anderson et al. 2004; He and Chinese 2004), it was possible to develop a model of the virus transmission that takes into account the effect of the ABO polymorphism.”
BackgroundThe SARS-CoV S glycoprotein: expression and functional characterization
Xiao, X., Chakraborti, S., Dimitrov, A. S., Gramatikoff, K., & Dimitrov, D. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.054 · Cited by 370
ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome
(2005) · JAMA · doi:10.1001/jama.293.12.1450-c · Cited by 350
Human Coronaviruses: What Do They Cause?
Van Der Hoek, L. (2007) · Antiviral Therapy · doi:10.1177/135965350701200s01.1 · Cited by 331
Marionneau, S., Cailleau-Thomas, A., Rocher, J., Le Moullac-Vaidye, B., Ruvoën, N., Clément, M., & Le Pendu, J. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01321-9 · Cited by 326
Self-citationKeyaerts, E., Vijgen, L., Pannecouque, C., Van Damme, E., Peumans, W., Egberink, H., Balzarini, J., & Van Ranst, M. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.03.003 · Cited by 294
Li, W., Wong, S.-K., Li, F., Kuhn, J. H., Huang, I.-C., Choe, H., & Farzan, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4211-4219.2006 · Cited by 276
Chen, J., & Subbarao, K. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141706 · Cited by 251
Babcock, G. J., Esshaki, D. J., Thomas, W. D., & Ambrosino, D. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4552-4560.2004 · Cited by 243
Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses
Stäger, S., Alexander, J., Kirby, A. C., Botto, M., Rooijen, N. V., Smith, D. F., Brombacher, F., & Kaye, P. M. (2003) · Nature Medicine · doi:10.1038/nm933 · Cited by 213
Blood group antigens: molecules seeking a function?
Greenwell, P. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018581503164 · Cited by 165
Mass Spectrometric Characterization of Proteins from the SARS Virus
Krokhin, O., Li, Y., Andonov, A., Feldmann, H., Flick, R., Jones, S., Stroeher, U., Bastien, N., Dasuri, K. V. N., Cheng, K., et al. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300048-mcp200 · Cited by 163
Han, D. P., Lohani, M., & Cho, M. W. (2007) · Journal of Virology · doi:10.1128/jvi.00315-07 · Cited by 157
Chakraborti, S., Prabakaran, P., Xiao, X., & Dimitrov, D. S. (2005) · Virology Journal · doi:10.1186/1743-422x-2-73 · Cited by 95
Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus
Ying, W., Hao, Y., Zhang, Y., Peng, W., Qin, E.-D., Cai, Y., Wei, K., Wang, J., Chang, G., Sun, W., et al. (2004) · PROTEOMICS · doi:10.1002/pmic.200300676 · Cited by 90
Neil, S. J. D., McKnight, Á., Gustafsson, K. T., & Weiss, R. A. (2005) · Blood · doi:10.1182/blood-2004-11-4267 · Cited by 85
Preece, A. F., Strahan, K. M., Devitt, J., Yamamoto, F.-I., & Gustafsson, K. (2002) · Blood · doi:10.1182/blood.v99.7.2477 · Cited by 66
Arendrup, M. C., Hansen, J. S., Clausen, H., Nielsen, C. H., Mathiesen, L. R., & Nielsen, J. O. (1991) · AIDS · doi:10.1097/00002030-199104000-00014 · Cited by 57
Evolution of the human ABO polymorphism by two complementary selective pressures
Seymour, R. M., Allan, M. J., Pomiankowski, A., & Gustafsson, K. T. (2004) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2004.2674 · Cited by 45
Mollicone, R., Cailleau, A., Imberty, A., Gane, P., Pérez, S., & Oriol, R. (1996) · Glycoconjugate Journal · doi:10.1007/bf00731501 · Cited by 37
Virus recognition by specific natural antibodies and complement results in MHC I cross‐presentation
Dürrbach, A., Baple, E. L., Preece, A., Charpentier, B., & Gustafsson, K. T. (2007) · European Journal of Immunology · doi:10.1002/eji.200636129 · Cited by 30
Chou, C.-F., Shen, S., Tan, Y., Fielding, B. C., Tan, T. H. P., Fu, J., Xu, Q., Lim, S. G., & Hong, W. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.09.008 · Cited by 24
Self-citationComparison of the three rat GDP‐L‐fucose:β‐D‐galactoside 2‐α‐L‐fucosyltransferases FTA, FTB and FTC
Bureau, V., Marionneau‐Lambot, S., Cailleau–Thomas, A., Moullac‐Vaidye, B. L., Liehr, T., & LePendu, J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01962.x · Cited by 21
Self-citationCloning of a rat gene encoding the histo‐blood group A enzyme
Cailleau–Thomas, A., Moullac‐Vaidye, B. L., Rocher, J., Bouhours, D., Szpirer, C., & LePendu, J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03094.x · Cited by 14
Self-citation
Cited by
Menter, T., Haslbauer, J. D., Nienhold, R., Savic, S., Hopfer, H., Deigendesch, N., Frank, S., Turek, D., Willi, N., Pargger, H., et al. (2020) · Histopathology · doi:10.1111/his.14134 · Cited by 1,230
Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility
Zhao, J., Yang, Y., Huang, H., Li, D., Gu, D., Lu, X., Zhang, Z., Liu, L., Liu, T., Liu, Y., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1150 · Cited by 853
Blood Groups in Infection and Host Susceptibility
Cooling, L. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-14 · Cited by 632
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103474 · Cited by 395
The complement system in COVID-19: friend and foe?
Java, A., Apicelli, A. J., Liszewski, M. K., Coler-Reilly, A., Atkinson, J. P., Kim, A. H. J., & Kulkarni, H. S. (2020) · JCI Insight · doi:10.1172/jci.insight.140711 · Cited by 376
Metadata
- Authors
- Guillon, P., Clément, M., Sébille, V., Rivain, J.-G., Chou, C.-F., Ruvoën-Clouet, N., & Le Pendu, J.
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09-25
- Volume
- 18
- Issue
- 12
- Pages
- 1085-1093
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2129867060
- Cited by
- 411
- References
- 30
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.